Browse AMR Mutations
Explore antimicrobial resistance mutations from the literature
Explore antimicrobial resistance mutations from the literature
Overview
Molecular Epidemiology, Antimicrobial Surveillance, and PK/PD Analysis to Guide the Treatment of Neisseria gonorrhoeae Infections.
Mutations in the gyrA gene contribute to ciprofloxacin resistance.
The antimicrobial resistance landscape of Neisseria gonorrhoeae in New Zealand from November 2018 to March 2019 and the role of sexual orientation in transmission.
Mutations in gyrA contribute to resistance to ciprofloxacin.
Potential of nanopore sequencing for tuberculosis diagnosis and drug resistance detection.
Molecular epidemiology of drug-resistant Neisseria gonorrhoeae in Russia (Current Status, 2015).
Neisseria gonorrhoeae gyrA with mutations conferring resistance to fluoroquinolones; CARD accession: CARD:3003928
Development and characterisation of highly antibiotic resistant Bartonella bacilliformis mutants.
WGS to predict antibiotic MICs for Neisseria gonorrhoeae.
Emergence and evolution of antimicrobial resistance genes and mutations in Neisseria gonorrhoeae.
Genomic surveillance of Neisseria gonorrhoeae in the Philippines, 2013-2014.
Clinical characteristics and genomic epidemiological survey of tuberculosis in Wuzhou, China, 2022.
Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC.
Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.
High prevalence of mutations in quinolone-resistance-determining regions and mtrR loci in polyclonal Neisseria gonorrhoeae isolates at a tertiary hospital in Southern Taiwan.
Mutations in gyrA were associated with ciprofloxacin resistance.
Summary and Trends of the Russian Gonococcal Antimicrobial Surveillance Programme, 2005 to 2016.
Genotypic and Phenotypic Characterization of Antimicrobial Resistance in Neisseria gonorrhoeae: a Cross-Sectional Study of Isolates Recovered from Routine Urine Cultures in a High-Incidence Setting.
Antimicrobial resistance and heterogeneity of Neisseria gonorrhoeae isolated from patients attending sexually transmitted infection clinics in Lusaka, Zambia.
Target enrichment improves culture-independent detection of Neisseria gonorrhoeae and antimicrobial resistance determinants direct from clinical samples with Nanopore sequencing.
Target-Mediated Fluoroquinolone Resistance in Neisseria gonorrhoeae: Actions of Ciprofloxacin against Gyrase and Topoisomerase IV.
Whole-Genome Sequencing of Russian Neisseria Gonorrhoeae Isolates Related to ST 1407 Genogroup.
Assessment of Antibiotic Resistance and Efflux Pump Gene Expression in Neisseria Gonorrhoeae Isolates from South Africa by Quantitative Real-Time PCR and Regression Analysis.
associated with decreased expression
The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic.
Cephalosporin-Resistant Neisseria gonorrhoeae Clone, China
Whole genome analysis and antimicrobial resistance of Neisseria gonorrhoeae isolates from Ghana.
Mutations in gyrA were linked to fluoroquinolone resistance.
Continuing genomic evolution of the Neisseria meningitidis cc11.2 urethritis clade, NmUC: a narrative review.
Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from India, Pakistan and Bhutan in 2007-2011.
Mutations in the gyrA gene contribute to resistance to ciprofloxacin.
Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.
Results in resistance to ciprofloxacin.
Whole-genome sequencing reveals transmission of gonococcal antibiotic resistance among men who have sex with men: an observational study.
Genomic epidemiology and antimicrobial resistance of Neisseria gonorrhoeae in New Zealand.
The novel 2024 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations and superseded WHO N. gonorrhoeae reference strains-phenotypic, genetic and reference genome characterization.
carried various mutations leading to fluoroquinolone resistance
Interactions between Zoliflodacin and Neisseria gonorrhoeae Gyrase and Topoisomerase IV: Enzymological Basis for Cellular Targeting.
Mutations in gyrA increase susceptibility to zoliflodacin.
Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates.
gyrA
Whole-Genome Sequencing to Predict Antimicrobial Susceptibility Profiles in Neisseria gonorrhoeae.
gyrA
Characterization of DNA Gyrase Activity and Elucidation of the Impact of Amino Acid Substitution in GyrA on Fluoroquinolone Resistance in Mycobacterium avium.
Mycobacterium avium gyrA with mutation conferring resistance to fluoroquinolone; CARD accession: CARD:3007473
Letter: Normotensive phaeochromocytoma with hypercalcaemia.
Mutation often seen together with S91F mutation (PMID: 23347339)
Mutations in gyrA, gyrB, parC, and parE in quinolone-resistant strains of Neisseria gonorrhoeae.
Mutation often seen together with S91F mutation (PMID: 23347339)
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research